Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
1998 | 1 |
2003 | 1 |
2004 | 1 |
2024 | 0 |
Search Results
3 results
Results by year
Citations
1
article
found by citation matching
Effect of polyoxidonium on the phagocytic activity of human peripheral blood leukocytes.
Russ J Immunol. 2003.
PMID: 12717555
Search results
Filters applied: . Clear all
Page 1
Did you mean
effect of polyoxydonium on the phagocytic activity of human peripheral blood leukocytes
(2 results)?
Effect of polyoxidonium on the phagocytic activity of human peripheral blood leukocytes.
Dambaeva SV, Mazurov DV, Golubeva NM, D'yakonova VA, Pinegin BV, Khaitov RM.
Dambaeva SV, et al.
Russ J Immunol. 2003 Apr;8(1):53-60.
Russ J Immunol. 2003.
PMID: 12717555
The effect of polyoxidonium on the functional activity of human peripheral blood phagocytes was studied in vitro. ...Polyoxidonium proved to have an antioxidant activity at all doses tested (100, 250, and 500 &mgr …
The effect of polyoxidonium on the functional activity of human peripheral blood phagocytes …
Item in Clipboard
Study of interaction between the polyoxidonium immunomodulator and the human immune system cells.
Dyakonova VA, Dambaeva SV, Pinegin BV, Khaitov RM.
Dyakonova VA, et al.
Int Immunopharmacol. 2004 Dec 15;4(13):1615-23. doi: 10.1016/j.intimp.2004.07.015.
Int Immunopharmacol. 2004.
PMID: 15454114
Polyoxidonium (PO) is a high-molecular weight physiologically active compound with pronounced immunomodulating activity, an N-oxidized polyethylene-piperazine derivative. The aim of our work was to study cellular and molecular mechanisms of the action of PO o …
Polyoxidonium (PO) is a high-molecular weight physiologically active compound with pronounced immunomodulating activity …
Item in Clipboard
[Clinical trial of domestic drug polyoxidonium in secondary immunodeficiency].
Borisova AM, Laktionova LV, Setdikova NKh.
Borisova AM, et al.
Ter Arkh. 1998;70(10):52-7.
Ter Arkh. 1998.
PMID: 9864806
Clinical Trial.
Russian.
MATERIALS AND METHODS: 56 patients entered the trial; 13 with CB in remission, 22 with CB in exacerbation and 21 with chronic recurrent furunculosis. Clinical examinations and tests were made before polyoxidonium therapy and 2-3 days after it. Immunological tests consisted …
MATERIALS AND METHODS: 56 patients entered the trial; 13 with CB in remission, 22 with CB in exacerbation and 21 with chronic recurrent furu …
Item in Clipboard
Cite
Cite